Join us for the Adapting Clinical Strategies for Rapid Response webinar on November 28, 2024. In today’s global landscape, clinical trials often face challenges from geopolitical uncertainties, including conflict zones, climate change, natural disasters, pandemics, and migration. This webinar will address the critical strategies, challenges, and opportunities for conducting clinical research in these uncertain environments.
The panel will discuss key topics such as community engagement, ethical considerations, and alternative study designs that can adapt to security risks, cultural sensitivities, and limited resources. We’ll explore the sponsor’s challenges in terms of security, logistics, and recruitment, as well as the potential opportunities for addressing unmet medical needs and building positive public health impacts.
Participants will also learn about essential contingency planning, including data integrity and security, site and staff management, and technology adaptation for remote monitoring. The discussion will cover real-world experiences and provide practical insights on navigating regulatory landscapes, ensuring participant safety.
The session will be moderated by Catalin Crai, Novotech Therapeutic Strategy Manager, and includes these expert panelists:
- Dr. Nancy Shulman, Chief Medical Officer, BlueJay Therapeutics.
- Dr. Ivan Vyshnyvetskyy, President at Ukrainian Association for Clinical Research.
- Adrian Karrer, Senior Regional Operations Director, Marken.
- Dr. David Ng, Vice President of Biometrics, Novotech.
Don’t miss this vital discussion on ensuring the resilience of clinical trials in the current environment.